AFL Stock - Aflac Incorporated
Unlock GoAI Insights for AFL
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $19.13B | $18.84B | $19.15B | $21.55B | $22.26B |
| Gross Profit | $6.82B | $18.84B | $19.15B | $21.55B | $22.26B |
| Gross Margin | 35.6% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Income | $6.42B | $5.26B | $4.87B | $5.21B | $4.16B |
| Net Income | $5.44B | $4.66B | $4.42B | $4.23B | $4.78B |
| Net Margin | 28.5% | 24.7% | 23.1% | 19.6% | 21.5% |
| EPS | $9.68 | $7.81 | $6.96 | $6.42 | $6.69 |
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 16th 2025 | Mizuho | Initiation | Underperform | $104 |
| January 23rd 2025 | BMO Capital Markets | Initiation | Market Perform | $111 |
| October 9th 2024 | TD Cowen | Initiation | Hold | $102 |
| September 5th 2024 | Barclays | Initiation | Underweight | $96 |
| January 4th 2024 | Evercore ISI | Downgrade | Underperform | $78← $76 |
| August 18th 2023 | Morgan Stanley | Downgrade | Equal Weight | $75← $74 |
| June 5th 2023 | BofA Securities | Resumed | Buy | $77 |
| April 25th 2023 | Wells Fargo | Initiation | Equal Weight | $73 |
| May 24th 2022 | Citigroup | Initiation | Neutral | $60 |
Earnings History & Surprises
AFLEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 28, 2026 | — | — | — | — |
Q1 2026 | Feb 4, 2026 | $1.74 | — | — | — |
Q4 2025 | Nov 4, 2025 | $1.77 | $2.49 | +40.7% | ✓ BEAT |
Q3 2025 | Aug 5, 2025 | $1.70 | $1.78 | +4.7% | ✓ BEAT |
Q2 2025 | Apr 30, 2025 | $1.67 | $1.66 | -0.6% | ✗ MISS |
Q1 2025 | Feb 5, 2025 | $1.62 | $1.56 | -3.7% | ✗ MISS |
Q4 2024 | Oct 30, 2024 | $1.69 | $2.16 | +27.8% | ✓ BEAT |
Q3 2024 | Jul 31, 2024 | $1.60 | $1.83 | +14.4% | ✓ BEAT |
Q2 2024 | May 1, 2024 | $1.58 | $1.66 | +5.1% | ✓ BEAT |
Q1 2024 | Jan 31, 2024 | $1.45 | $1.25 | -13.8% | ✗ MISS |
Q4 2023 | Nov 1, 2023 | $1.44 | $1.84 | +27.8% | ✓ BEAT |
Q3 2023 | Aug 1, 2023 | $1.42 | $1.58 | +11.3% | ✓ BEAT |
Q2 2023 | Apr 26, 2023 | $1.40 | $1.55 | +10.7% | ✓ BEAT |
Q1 2023 | Feb 1, 2023 | $1.21 | $1.29 | +6.6% | ✓ BEAT |
Q4 2022 | Oct 31, 2022 | $1.22 | $1.23 | +0.8% | ✓ BEAT |
Q3 2022 | Aug 1, 2022 | $1.29 | $1.46 | +13.2% | ✓ BEAT |
Q2 2022 | Apr 27, 2022 | $1.37 | $1.42 | +3.6% | ✓ BEAT |
Q1 2022 | Feb 2, 2022 | $1.27 | $1.28 | +0.8% | ✓ BEAT |
Q4 2021 | Oct 27, 2021 | $1.32 | $1.53 | +15.9% | ✓ BEAT |
Q3 2021 | Jul 28, 2021 | $1.27 | $1.59 | +25.2% | ✓ BEAT |
Latest News
Mizuho Initiates Coverage On Aflac with Underperform Rating, Announces Price Target of $104
📉 NegativeMorgan Stanley Maintains Equal-Weight on Aflac, Raises Price Target to $118
➖ NeutralAFLAC Increases Quarterly Dividend From $0.58 To $0.61 Per Share
📈 PositiveWells Fargo Maintains Equal-Weight on Aflac, Raises Price Target to $109
➖ NeutralEvercore ISI Group Maintains Underperform on Aflac, Raises Price Target to $111
➖ NeutralJP Morgan Maintains Neutral on Aflac, Raises Price Target to $101
➖ NeutralAflac shares are trading higher after the company reported earnings and revenue that beat analyst estimates.
📈 PositiveBarclays Maintains Underweight on Aflac, Raises Price Target to $104
➖ NeutralAflac Q3 Adj. EPS $2.49 Beats $1.77 Estimate, Sales $4.740B Beat $4.383B Estimate
📈 PositiveKeefe, Bruyette & Woods Maintains Market Perform on Aflac, Raises Price Target to $110
📈 PositiveEvercore ISI Group Maintains Underperform on Aflac, Raises Price Target to $110
➖ NeutralBarclays Maintains Underweight on Aflac, Raises Price Target to $102
➖ NeutralMorgan Stanley Maintains Equal-Weight on Aflac, Raises Price Target to $113
➖ NeutralFrequently Asked Questions about AFL
What is AFL's current stock price?
What is the analyst price target for AFL?
What sector is Aflac Incorporated in?
What is AFL's market cap?
Does AFL pay dividends?
Similar Stocks
Financial Services SectorExplore stocks similar to AFL for comparison